A proof of concept Phase IIb efficacy trial to evaluate the protective efficacy of a booster MVA85A vaccination administered to BCG primed infants in the Western Cape. (360G-Wellcome-084785_Z_08_B)

£177,839

Do not Publish

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 177839
Applicant Surname McShane
Approval Committee Innovations Strategy Panel
Award Date 2013-05-28T00:00:00+00:00
Financial Year 2012/13
Grant Programme: Title Strategic Award - Innovations
Internal ID 084785/Z/08/B
Lead Applicant Prof Helen McShane
Partnership Value 177839
Planned Dates: End Date 2013-11-27T00:00:00+00:00
Planned Dates: Start Date 2013-05-28T00:00:00+00:00
Recipient Org: Country United Kingdom
Region South East